FIELD: medicine. SUBSTANCE: invention proposes a novel agent in complex treatment of patients with systemic lupus erythematosis. This agent is the known actoprotecting agent bemithyl. Prescription of bemithyl ensures to enhance therapy effectiveness significantly as compared with conventional schedule of treatment of patients with systemic lupus erythema-tosis, to prolong remission period and decrease prednisolone dose which provides positive effect in progressive dosage increase in conventional schedule of treatment. EFFECT: enhanced effectiveness of agent. 3 tbl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS | 2015 |
|
RU2580301C1 |
| METHOD OF DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME IN CHILDREN | 2010 |
|
RU2435524C1 |
| METHOD FOR TREATING OSTEOARTHROSIS CASES AGGRAVATED WITH REACTIVE SYNOVITIS | 2005 |
|
RU2314820C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND SJOGREN DISEASE | 2023 |
|
RU2817079C1 |
| METHOD FOR PREVENTING OSSEOUS-CARTILAGINOUS DESTRUCTION IN CASE OF RHEUMATOID ARTHRITIS | 2003 |
|
RU2268719C2 |
| METHOD FOR TREATMENT OF JUVENILE RHEUMATIC ARTHRITIS | 1991 |
|
RU2018320C1 |
| METHOD OF TREATING PATIENTS WITH RADIATION EXUDATIVE PERICARDITIS | 2009 |
|
RU2415667C1 |
| METHOD FOR PREDICTION OF RISK OF DELAYED DYSKINESIA ACCOMPANYING NEUROLEPTIC THERAPY IN SCHIZOPHRENICS | 2010 |
|
RU2447832C1 |
| METHOD FOR PREVENTION OF OSTEOPOROSIS ACCOMPANYING PREOPERATIVE CHEMOTHERAPY IN PATIENTS SUFFERING STAGE III NON-SMALL-CELL LUNG CANCER | 2010 |
|
RU2452483C1 |
| METHOD FOR TREATING THE CASES OF SYSTEMIC LUPUS ERYTHEMATOSUS | 0 |
|
SU1697817A1 |
